However, our results are more in line with the findings of a pooled analysis of data from 19 studies on 10319 individual patients with early breast cancer which found the beneficial, positive effect of PIK3CA mutation on invasive disease-free survival, as well as with the findings of several smaller primary studies [24, 25]. The gene discussed is PIK3CA; the disease is breast carcinoma.